Stock listing
A3ES4X Stock Price, News, Filings & Events — Skye Bioscience, Inc.
Selected listing: A3ES4X · LS · EUR · DE
This page tracks Skye Bioscience, Inc.'s A3ES4X:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ES4X:LS. A3ES4X:LS is the stock-level entry point for investors researching Skye Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3ES4X:LS
- Asset type
- Stock
- Market cap
- $9.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Skye Bioscience, Inc. A3ES4X:LS stock context
This page tracks Skye Bioscience, Inc.'s A3ES4X:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ES4X:LS. A3ES4X:LS is the stock-level entry point for investors researching Skye Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Skye Bioscience, Inc.
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
August 14, 2026
SkyVolt Energy Signs LOI with Modular Data Center Company Nodiac.ai, Unlocking Potential Additional Revenue from strategic Existing and F...
June 18, 2026
Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated i...
May 20, 2026
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 12, 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 11, 2026
Skye Bioscience, Inc. earnings calls
Skye Bioscience, Inc. (SKYE) Q4 2025 Earnings Call
March 10, 2026 · Replay with transcript and chapters
Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Skye Bioscience, Inc. (SKYE) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Skye Bioscience, Inc. (SKYE) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call
March 20, 2025 · Replay with transcript and chapters
Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call
November 7, 2024 · Replay with transcript and chapters
Research Skye Bioscience, Inc.
Skye Bioscience, Inc. investor report
Review AI stock analysis and investor report context for A3ES4X:LS.
Skye Bioscience, Inc. company profile
View the public company page for Skye Bioscience, Inc. on 6ix.
Skye Bioscience, Inc. news
Read company news and market updates connected to Skye Bioscience, Inc..
Skye Bioscience, Inc. investor events
Find investor webinars, events, and replay context for Skye Bioscience, Inc..
Alternate listings
SKYE:NASDAQ
US · USD
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is A3ES4X:LS.
A3ES4X:LSX
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is A3ES4X:LS.
SKYE:BOATS
US · USD
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is A3ES4X:LS.
09R:FWB
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is A3ES4X:LS.
09R:DUS
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is A3ES4X:LS.